Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-115902
Filing Date
2024-11-08
Accepted
2024-11-08 16:31:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2427608-1_424b5.htm 424B5 498293
2 GRAPHIC lg_apreatherapeutics-4c.jpg GRAPHIC 27485
  Complete submission text file 0001104659-24-115902.txt   536377
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276702 | Film No.: 241441137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)